http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-124465-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8f70c5b59b293a0220e30a752bb017f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
filingDate 1996-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8f08c753af9901f0b6b28d19e9570ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0c35739ea988f591dd9da28318601f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d2a0c473d8abbbc808ce4f8c802ca5f
publicationDate 2006-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-124465-A
titleOfInvention Reduction of infarct volume using citicoline
abstract THE INVENTION IS DIRECTED TO THE COMPOSITION AND USE OF CITICOLINE FOR THE PREPARATION OF A MEDICAMENT FOR REDUCING INFARCT VOLUME IN A PATIENT WHO HAS EXPERIENCED AN ISCHEMIC EVENT. A FIRST DOSE OF SAID MEDICAMENT COMPRISING AN EFFECTIVE AMOUNT OF CITICOLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IS ADMINISTERED SHORTLY AFTER AN ISCHEMIC EPISODE AND CONTINUING DAILY FOR UP TO ABOUT 30 DAYS, PREFERABLY FOR AT LEAST ABOUT 6 WEEKS. THE COMPOSITION COMPRISES OF AN EFFECTIVE AMOUNT OF CITICOLINE AND AT LEAST A SECOND THERAPEUTIC AGENT, OR THEIR RESPECTIVE PHARMACEUTICALLY ACCEPTABLE SALTS, IN A PHARMACEUTICALLY ACCEPTABLE CARRIER.
priorityDate 1995-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13804

Total number of triples: 16.